Nanostructured Delivery Systems for Curcumin: Improving Bioavailability and Plaque-Targeting Efficacy in Atherosclerosis
Pharmaceutics · 13.11.2025 · 17 (11) · 1465
DOI: 10.3390/pharmaceutics17111465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.11.2025. Verfasst von Yu Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: International Education Department, Henan Vocational College of Nursing, Anyang 455000, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, Key Project of Natural Science Foundation of Shandong Province, Plan on Science and Technology for Youth Innovation of Universities in Shandong Province.
Abstract (Originalsprache)
Cardiovascular disease (CVD) encompasses ischemic conditions of the heart, brain, and bodily tissues, primarily resulting from hyperlipidemia, atherosclerosis (AS), hypertension, and other related factors. CVD accounts for over 40% of global non-communicable disease mortality, making it the leading cause of death and a significant medical burden worldwide. AS, the principal pathological basis for most cardiovascular diseases, is characterized as a chronic, sterile inflammatory condition triggered by lipid overload and various other factors. In recent years, natural bioactive compounds have gained prominence in the treatment of human diseases. Among these, curcumin (Cur) has garnered considerable attention due to its anti-inflammatory, lipid-lowering, antihypertensive, and endothelial protective properties. This review examines traditional pharmacological approaches for treating AS, with particular emphasis on the critical mechanisms through which Cur exerts its therapeutic effects. Additionally, it introduces novel nanoformulations designed to address the inherent limitations of Cur, providing valuable insights for researchers investigating its application in AS therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Education Department, Henan Vocational College of Nursing, Anyang 455000, China.
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266073, China.
- Medical Psychology Center, Qingdao Special Servicemen Recuperation Center of PLA Navy, Qingdao 266021, China.
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
Förderung
- Shandong Provincial Natural Science Foundation
- Key Project of Natural Science Foundation of Shandong Province
- Plan on Science and Technology for Youth Innovation of Universities in Shandong Province
Zitieren
APA
Liu, Y., Yu, T., Zhang, C., Yang, Z., Yu, D., He, B., & Liang, Y. (2025). Nanostructured Delivery Systems for Curcumin: Improving Bioavailability and Plaque-Targeting Efficacy in Atherosclerosis. Pharmaceutics, 17(11), 1465. https://doi.org/10.3390/pharmaceutics17111465
Vancouver
Liu Y, Yu T, Zhang C, Yang Z, Yu D, He B, et al. Nanostructured Delivery Systems for Curcumin: Improving Bioavailability and Plaque-Targeting Efficacy in Atherosclerosis. Pharmaceutics. 2025;17(11):1465. doi:10.3390/pharmaceutics17111465
BibTeX
@article{Liu2025,
author = {Liu, Yu and Yu, Tengfei and Zhang, Chao and Yang, Zhiyong and Yu, Dahai and He, Bin and Liang, Yan},
title = {Nanostructured Delivery Systems for Curcumin: Improving Bioavailability and Plaque-Targeting Efficacy in Atherosclerosis},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {11},
pages = {1465},
doi = {10.3390/pharmaceutics17111465}
}
EUVIMED